Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Accumulated Depreciation & Amortization (2022 - 2023)

Historic Accumulated Depreciation & Amortization for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $316000.0.

  • Lexeo Therapeutics' Accumulated Depreciation & Amortization changed N/A to $316000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $316000.0, marking a year-over-year change of. This contributed to the annual value of $133000.0 for FY2022, which is N/A changed from last year.
  • Lexeo Therapeutics' Accumulated Depreciation & Amortization amounted to $316000.0 in Q3 2023.
  • Over the past 5 years, Lexeo Therapeutics' Accumulated Depreciation & Amortization peaked at $316000.0 during Q3 2023, and registered a low of $133000.0 during Q4 2022.